- Home
- TENX vs XCUR Comparison
TENX vs XCUR Comparison
Compare TENX & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- XCUR
- Stock Information
- Founded
- TENX 1967
- XCUR 2011
- Country
- TENX United States
- XCUR United States
- Employees
- TENX N/A
- XCUR N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- XCUR Health Care
- Exchange
- TENX Nasdaq
- XCUR Nasdaq
- Market Cap
- TENX 27.3M
- XCUR 32.4M
- IPO Year
- TENX N/A
- XCUR N/A
- Fundamental
- Price
- TENX $7.79
- XCUR $5.32
- Analyst Decision
- TENX Strong Buy
- XCUR
- Analyst Count
- TENX 4
- XCUR 0
- Target Price
- TENX $16.67
- XCUR N/A
- AVG Volume (30 Days)
- TENX 119.0K
- XCUR 33.2K
- Earning Date
- TENX 11-12-2025
- XCUR 11-13-2025
- Dividend Yield
- TENX N/A
- XCUR N/A
- EPS Growth
- TENX N/A
- XCUR N/A
- EPS
- TENX N/A
- XCUR N/A
- Revenue
- TENX N/A
- XCUR N/A
- Revenue This Year
- TENX N/A
- XCUR N/A
- Revenue Next Year
- TENX N/A
- XCUR N/A
- P/E Ratio
- TENX N/A
- XCUR N/A
- Revenue Growth
- TENX N/A
- XCUR N/A
- 52 Week Low
- TENX $3.25
- XCUR $2.15
- 52 Week High
- TENX $7.98
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- TENX 77.22
- XCUR 50.73
- Support Level
- TENX $7.45
- XCUR $4.12
- Resistance Level
- TENX $7.82
- XCUR $4.57
- Average True Range (ATR)
- TENX 0.31
- XCUR 0.32
- MACD
- TENX 0.06
- XCUR 0.16
- Stochastic Oscillator
- TENX 84.50
- XCUR 92.34
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.